Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 78

1.

Unchain My Blood: Lessons Learned from Self-Assembled Dendrimers as Nanoscale Heparin Binders.

Marson D, Laurini E, Aulic S, Fermeglia M, Pricl S.

Biomolecules. 2019 Aug 20;9(8). pii: E385. doi: 10.3390/biom9080385. Review.

2.

Evolution from Covalent to Self-Assembled PAMAM-Based Dendrimers as Nanovectors for siRNA Delivery in Cancer by Coupled In Silico-Experimental Studies. Part I: Covalent siRNA Nanocarriers.

Marson D, Laurini E, Aulic S, Fermeglia M, Pricl S.

Pharmaceutics. 2019 Jul 18;11(7). pii: E351. doi: 10.3390/pharmaceutics11070351. Review.

3.

Evolution from Covalent to Self-Assembled PAMAM-Based Dendrimers as Nanovectors for siRNA Delivery in Cancer by Coupled in Silico-Experimental Studies. Part II: Self-Assembled siRNA Nanocarriers.

Laurini E, Marson D, Aulic S, Fermeglia M, Pricl S.

Pharmaceutics. 2019 Jul 10;11(7). pii: E324. doi: 10.3390/pharmaceutics11070324. Review.

4.

Dichloro-Phenyl-Benzotriazoles: A New Selective Class of Human Respiratory Syncytial Virus Entry Inhibitors.

Piras S, Sanna G, Carta A, Corona P, Ibba R, Loddo R, Madeddu S, Caria P, Aulic S, Laurini E, Fermeglia M, Pricl S.

Front Chem. 2019 Apr 16;7:247. doi: 10.3389/fchem.2019.00247. eCollection 2019.

5.

Design, synthesis and antitubercular activity of 4-alkoxy-triazoloquinolones able to inhibit the M. tuberculosis DNA gyrase.

Carta A, Bua A, Corona P, Piras S, Briguglio I, Molicotti P, Zanetti S, Laurini E, Aulic S, Fermeglia M, Pricl S.

Eur J Med Chem. 2019 Jan 1;161:399-415. doi: 10.1016/j.ejmech.2018.10.031. Epub 2018 Oct 17.

PMID:
30384044
6.

Correction: Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment.

Ziouziou H, Andrieu C, Laurini E, Karaki S, Fermeglia M, Oueslati R, Taieb D, Camplo M, Siri O, Pricl S, Katsogiannou M, Rocchi P.

Oncotarget. 2018 Jun 19;9(47):28797. doi: 10.18632/oncotarget.25683. eCollection 2018 Jun 19.

7.

Quinoxaline derivatives as new inhibitors of coxsackievirus B5.

Carta A, Sanna G, Briguglio I, Madeddu S, Vitale G, Piras S, Corona P, Peana AT, Laurini E, Fermeglia M, Pricl S, Serra A, Carta E, Loddo R, Giliberti G.

Eur J Med Chem. 2018 Feb 10;145:559-569. doi: 10.1016/j.ejmech.2017.12.083. Epub 2017 Dec 27.

PMID:
29339251
8.

9-Aminoacridine-based agents impair the bovine viral diarrhea virus (BVDV) replication targeting the RNA-dependent RNA polymerase (RdRp).

Loddo R, Francesconi V, Laurini E, Boccardo S, Aulic S, Fermeglia M, Pricl S, Tonelli M.

Bioorg Med Chem. 2018 Feb 15;26(4):855-868. doi: 10.1016/j.bmc.2018.01.001. Epub 2018 Jan 4.

PMID:
29325885
9.

Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment.

Ziouziou H, Andrieu C, Laurini E, Karaki S, Fermeglia M, Oueslati R, Taieb D, Camplo M, Siri O, Pricl S, Katsogiannou M, Rocchi P.

Oncotarget. 2017 Aug 24;8(44):77317-77329. doi: 10.18632/oncotarget.20469. eCollection 2017 Sep 29. Erratum in: Oncotarget. 2018 Jun 19;9(47):28797.

10.

Triazolopyridinyl-acrylonitrile derivatives as antimicrotubule agents: Synthesis, in vitro and in silico characterization of antiproliferative activity, inhibition of tubulin polymerization and binding thermodynamics.

Briguglio I, Laurini E, Pirisi MA, Piras S, Corona P, Fermeglia M, Pricl S, Carta A.

Eur J Med Chem. 2017 Dec 1;141:460-472. doi: 10.1016/j.ejmech.2017.09.065. Epub 2017 Oct 3.

PMID:
29055869
11.

Molecular and functional characterization of a new 3' end KIT juxtamembrane deletion in a duodenal GIST treated with neoadjuvant Imatinib.

Perfetti V, Laurini E, Aulić S, Fermeglia M, Riboni R, Lucioni M, Dallera E, Delfanti S, Pugliese L, Latteri FS, Pietrabissa A, Pricl S.

Oncotarget. 2017 Jul 18;8(34):56158-56167. doi: 10.18632/oncotarget.19341. eCollection 2017 Aug 22.

12.

3D Homology Model of Sigma1 Receptor.

Laurini E, Marson D, Fermeglia M, Pricl S.

Handb Exp Pharmacol. 2017;244:27-50. doi: 10.1007/164_2017_35. Review.

PMID:
28667476
13.

β-Catenin in desmoid-type fibromatosis: deep insights into the role of T41A and S45F mutations on protein structure and gene expression.

Colombo C, Belfiore A, Paielli N, De Cecco L, Canevari S, Laurini E, Fermeglia M, Pricl S, Verderio P, Bottelli S, Fiore M, Stacchiotti S, Palassini E, Gronchi A, Pilotti S, Perrone F.

Mol Oncol. 2017 Nov;11(11):1495-1507. doi: 10.1002/1878-0261.12101. Epub 2017 Sep 29.

14.

Thiazole-Based σ1 Receptor Ligands: Diversity by Late-Stage C-H Arylation of Thiazoles, Structure-Affinity and Selectivity Relationships, and Molecular Interactions.

Kokornaczyk AK, Schepmann D, Yamaguchi J, Itami K, Laurini E, Fermeglia M, Pricl S, Wünsch B.

ChemMedChem. 2017 Jul 6;12(13):1070-1080. doi: 10.1002/cmdc.201700166. Epub 2017 Jun 22.

PMID:
28544475
15.

Computer-assisted design, synthesis, binding and cytotoxicity assessments of new 1-(4-(aryl(methyl)amino)butyl)-heterocyclic sigma 1 ligands.

Zampieri D, Vio L, Fermeglia M, Pricl S, Wünsch B, Schepmann D, Romano M, Mamolo MG, Laurini E.

Eur J Med Chem. 2016 Oct 4;121:712-726. doi: 10.1016/j.ejmech.2016.06.001. Epub 2016 Jun 3.

PMID:
27366902
16.

Mastering Dendrimer Self-Assembly for Efficient siRNA Delivery: From Conceptual Design to In Vivo Efficient Gene Silencing.

Chen C, Posocco P, Liu X, Cheng Q, Laurini E, Zhou J, Liu C, Wang Y, Tang J, Col VD, Yu T, Giorgio S, Fermeglia M, Qu F, Liang Z, Rossi JJ, Liu M, Rocchi P, Pricl S, Peng L.

Small. 2016 Jul;12(27):3667-76. doi: 10.1002/smll.201503866. Epub 2016 May 31.

17.

Rigidity versus Flexibility: Is This an Issue in σ1 Receptor Ligand Affinity and Activity?

Weber F, Brune S, Börgel F, Lange C, Korpis K, Bednarski PJ, Laurini E, Fermeglia M, Pricl S, Schepmann D, Wünsch B.

J Med Chem. 2016 Jun 9;59(11):5505-19. doi: 10.1021/acs.jmedchem.6b00585. Epub 2016 May 23.

PMID:
27156565
18.

Highly grafted polystyrene/polyvinylpyridine polymer gold nanoparticles in a good solvent: effects of chain length and composition.

Posel Z, Posocco P, Lísal M, Fermeglia M, Pricl S.

Soft Matter. 2016 Apr 21;12(15):3600-11. doi: 10.1039/c5sm02867a.

PMID:
26980360
19.

Synthesis, cytotoxicity and antiviral evaluation of new series of imidazo[4,5-g]quinoline and pyrido[2,3-g]quinoxalinone derivatives.

Briguglio I, Loddo R, Laurini E, Fermeglia M, Piras S, Corona P, Giunchedi P, Gavini E, Sanna G, Giliberti G, Ibba C, Farci P, La Colla P, Pricl S, Carta A.

Eur J Med Chem. 2015 Nov 13;105:63-79. doi: 10.1016/j.ejmech.2015.10.002. Epub 2015 Oct 9.

PMID:
26479028
20.

Hitting the right spot: Mechanism of action of OPB-31121, a novel and potent inhibitor of the Signal Transducer and Activator of Transcription 3 (STAT3).

Brambilla L, Genini D, Laurini E, Merulla J, Perez L, Fermeglia M, Carbone GM, Pricl S, Catapano CV.

Mol Oncol. 2015 Jun;9(6):1194-206. doi: 10.1016/j.molonc.2015.02.012. Epub 2015 Mar 5.

Supplemental Content

Loading ...
Support Center